One number in the abstract
Where each one falls
Where it lands on the map
What it changes
Among 23 other studies
the abstract, start to end
Evolocumab reduced LDL-C levels by 66% (95% CI, 58% to 73%) to 75% …
← favours treatmentfavours comparator →
could be chanceLipids
−66.0−73.0 to −58.0
StatinsPCSK9 inhibitorsLipids
PCSK9 inhibitors × lipidshelps?settled
unlikelylikely
0.930.93 without it
Statins × lipidshelps?mixed
unlikelylikely
0.500.50 without it
← favours treatmentfavours comparator →
1 / 5